Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN(R) in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
No Comments »
Filed under: Pharmacy News
The Apothecary Shops, a Phoenix-based chain of specialty pharmacies with 16 locations in six states, has acquired the Greater Sacramento Specialty Pharmacy (GSP), a customer-service focused pharmacy with primary specialties in oncology and pain management.
No Comments »
Filed under: Pharmacy News
Celsion Corporation (Nasdaq: CLSN), a leading oncology drug development company, announced that the U.S. Food and Drug Administration (FDA) has designated the HEAT Study of its investigational drug, ThermoDox®, in combination with radiofrequency ablation (RFA), as a Fast Track Development Program…
No Comments »
Filed under: Pharmacy News
Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, announced the location of its new US headquarters in Bedminster, New Jersey. Archimedes has offices in a number of European countries and markets a range of therapeutics in Europe…
No Comments »
Filed under: Pharmacy News
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche’s key therapeutic areas, which include [...]
No Comments »
Filed under: Pharmacy News
US Oncology, Inc., the nation’s leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
No Comments »
Filed under: Pharmacy News
Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.
No Comments »
Filed under: Pharmacy News
When running early clinical trials for experimental new drugs across a range of therapeutic areas, demonstrating “proof of concept” is a critical milestone of the development process. It is at this stage where exploratory studies become confirmatory studies and there is a basis for studying the efficacy in a larger population…
No Comments »
Filed under: Pharmacy News
US Oncology, Inc., the nation’s leading integrated oncology company, announced that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration (FDA)…
No Comments »
Filed under: Pharmacy News
Neogenix Oncology, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 7,763,720, with claims related to DNAs encoding the novel molecular aspects of the Company’s NPC-1 antibody.
No Comments »
Filed under: Pharmacy News
